Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain

NCT06445465 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Alpha-Synucleinopathy
Parkinson's Disease
Dementia With Lewy Bodies
Multisystem Atrophy

Interventions

DRUG: [18F]MNI-1216

Sponsor

Invicro

Collaborators

[object Object]